EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Retrospective analysis of influences of sacubitril/valsartan in patients with diabetes with poorly controlled blood pressure in Japan

Shun Ito iD, Kazuo Kobayashi iD, Mari Sotozawa, Kyoji Chiba, Keiichi Chin, Hideo Shimura, Toshinao Tsuge, Hiroyuki Sakai, Takayuki Furuki, Atsushi Matsuzaki, Shinichi Nakajima, Nobukazu Takada und 8 weitere

Journal of Diabetes Investigation · 2025

DOI: 10.1111/jdi.70126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Shun Ito und 19 weiteren Autor:innen. Beteiligte Einrichtung: Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Kanagawa Prefecture, Japan. Hauptthemen laut MEDLINE: Biphenyl Compounds, Valsartan, Aminobutyrates, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Achieving optimal blood pressure control remains challenging, particularly for patients with diabetes. This post‐hoc study compared the efficacy and safety of switching to sacubitril/valsartan vs adding thiazide diuretics in this population.

Methods

This retrospective study included patients with diabetes and inadequate blood pressure control in the office or home settings despite combination therapy with renin‐angiotensin system inhibitors and calcium channel blockers. Patients were categorized into those receiving an additional thiazide diuretic (THZ group, n = 136) and those switching to sacubitril/valsartan (SacVal group, n = 199). The treatment effects over 12 months were analyzed using propensity score analysis with inverse probability weighting. Treatment discontinuation rates were assessed using the Cox proportional hazards model.

Results

In the propensity score analysis model, target pressure achievement rates were similar between the two groups. However, compared to the THZ group, the SacVal group exhibited significantly lower uric acid levels ( P < 0.001), improved glycated hemoglobin A 1c ( P = 0.02), and a smaller estimated glomerular filtration rate decline ( P = 0.02). Treatment discontinuation due to adverse events was significantly higher in the THZ group (13% vs 1%), with a hazard ratio of 11.53 (95% confidence interval: 2.66–49.93, P < 0.001).

Conclusions

The combination of sacubitril/valsartan with calcium channel blockers provided a similar reduction in blood pressure compared with thiazide with renin‐angiotensin system inhibitors and calcium channel blockers, and reported more favorable changes in uric acid levels, glycated hemoglobin A 1c , and estimated glomerular filtration rate, along with a significantly better treatment tolerability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biphenyl CompoundsValsartanAminobutyratesHypertensionBlood PressureTetrazolesAngiotensin Receptor AntagonistsAntihypertensive AgentsHumansRetrospective StudiesMaleFemaleDrug CombinationsAgedMiddle AgedJapanFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

Combination treatmentSacubitril/valsartanThiazide diuretics

Substanzen

Biphenyl CompoundsValsartanDrug CombinationsAminobutyratessacubitril and valsartan sodium hydrate drug combinationTetrazolesAngiotensin Receptor AntagonistsAntihypertensive Agents

Autor:innen und Institutionen

  • Committee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Kanagawa Prefecture, Japan.
  • Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa Prefecture, Japan.
  • Department of Nephrology, Yokohama Sakae Kyosai Hospital, Yokohama, Kanagawa Prefecture, Japan.
  • Department of Nephrology, Kitasato University School of Medicine, Sagamihara, Japan.
  • Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.

ORCID-Profile: Shun Ito, Kazuo Kobayashi

Zitieren

APA

Ito, S., Kobayashi, K., Sotozawa, M., Chiba, K., Chin, K., Shimura, H., Tsuge, T., Sakai, H., Furuki, T., Matsuzaki, A., Nakajima, S., Takada, N., Yamamoto, H., Takeda, H., Wakui, H., Iwasawa, T., Aoyama, T., Tamura, K., Toyoda, M., & Kanamori, A. (2025). Retrospective analysis of influences of sacubitril/valsartan in patients with diabetes with poorly controlled blood pressure in Japan. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70126

Vancouver

Ito S, Kobayashi K, Sotozawa M, Chiba K, Chin K, Shimura H, et al. Retrospective analysis of influences of sacubitril/valsartan in patients with diabetes with poorly controlled blood pressure in Japan. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.70126

BibTeX
@article{Ito2025,
  author = {Ito, Shun and Kobayashi, Kazuo and Sotozawa, Mari and Chiba, Kyoji and Chin, Keiichi and Shimura, Hideo and Tsuge, Toshinao and Sakai, Hiroyuki and Furuki, Takayuki and Matsuzaki, Atsushi and Nakajima, Shinichi and Takada, Nobukazu and Yamamoto, Hareaki and Takeda, Hiroshi and Wakui, Hiromichi and Iwasawa, Takamasa and Aoyama, Togo and Tamura, Kouichi and Toyoda, Masao and Kanamori, Akira},
  title = {Retrospective analysis of influences of sacubitril/valsartan in patients with diabetes with poorly controlled blood pressure in Japan},
  journal = {Journal of Diabetes Investigation},
  year = {2025},
  doi = {10.1111/jdi.70126}
}
Kostenlos starten →